Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008
Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma Source: International Congress 2018 – Basic pharmacology Year: 2018
Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006
Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
PDE-4-inhibitor rolipram supports treg-mediated suppression in a murine model of allergic airway disease Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008
Murine models of asthma Source: Eur Respir J 2003; 22: 374-382 Year: 2003
Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Effect of oral procaterol on allergic inflammation examined by a murine asthmatic model Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
In vivo evaluation of the airway epithelium in a murine model of allergic asthma: effects of bronchodilators on ciliary beat frequencySource: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006
The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001
Protective effect of thrombomodulin in a murine model of allergen-induced asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
Effect of budesonide/formoterol combination on an airway hyperresponsiveness and inflammation model in mice Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004